Literature DB >> 10866487

Ventricular arrhythmias and nonsedating antihistamines.

S Suissa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10866487      PMCID： PMC2014942          DOI： 10.1046/j.1365-2125.2000.00165.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  4 in total

1.  Risks of non-sedating antihistamines.

Authors:  M Lindquist; I R Edwards
Journal:  Lancet       Date:  1997-05-03       Impact factor: 79.321

2.  Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs.

Authors:  F J de Abajo; L A Rodríguez
Journal:  Br J Clin Pharmacol       Date:  1999-03       Impact factor: 4.335

3.  Risk of developing life-threatening ventricular arrhythmia associated with tefenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastine.

Authors:  C M Pratt; R P Hertz; B E Ellis; S P Crowell; W Louv; L Moyé
Journal:  Am J Cardiol       Date:  1994-02-15       Impact factor: 2.778

4.  Terfenadine-associated ventricular arrhythmias and QTc interval prolongation. A retrospective cohort comparison with other antihistamines among members of a health maintenance organization.

Authors:  J P Hanrahan; P W Choo; W Carlson; D Greineder; G A Faich; R Platt
Journal:  Ann Epidemiol       Date:  1995-05       Impact factor: 3.797
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.